Waters Corporation (NYSE:WAT) Receiving Favorable Media Coverage, Analysis Shows

News headlines about Waters Corporation (NYSE:WAT) have been trending positive on Saturday, according to Accern Sentiment Analysis. The research firm identifies negative and positive press coverage by analyzing more than twenty million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Waters Corporation earned a daily sentiment score of 0.26 on Accern’s scale. Accern also assigned news articles about the medical instruments supplier an impact score of 47.4036352003075 out of 100, indicating that recent press coverage is somewhat unlikely to have an effect on the stock’s share price in the next few days.

Here are some of the media stories that may have impacted Accern’s rankings:

A number of analysts have recently weighed in on the company. Zacks Investment Research raised Waters Corporation from a “hold” rating to a “buy” rating and set a $178.00 price objective for the company in a research report on Monday, April 24th. Cantor Fitzgerald reaffirmed a “buy” rating and set a $190.00 price target (up previously from $170.00) on shares of Waters Corporation in a research report on Tuesday, April 25th. Cowen and Company lifted their price objective on Waters Corporation from $160.00 to $175.00 and gave the company a “market perform” rating in a research note on Wednesday, April 26th. Barclays PLC set a $160.00 price target on Waters Corporation and gave the company a “hold” rating in a research note on Wednesday, April 26th. Finally, Deutsche Bank AG restated a “buy” rating and issued a $183.00 price target (up previously from $166.00) on shares of Waters Corporation in a research note on Saturday, April 29th. Two analysts have rated the stock with a sell rating, five have given a hold rating and seven have given a buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and an average target price of $186.00.

Waters Corporation (NYSE WAT) traded up 0.78% on Friday, reaching $177.03. The company’s stock had a trading volume of 414,729 shares. Waters Corporation has a 52 week low of $133.35 and a 52 week high of $187.65. The firm has a 50 day moving average price of $180.41 and a 200 day moving average price of $167.57. The stock has a market capitalization of $14.13 billion, a P/E ratio of 26.68 and a beta of 0.84.

Waters Corporation (NYSE:WAT) last released its quarterly earnings results on Tuesday, July 25th. The medical instruments supplier reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.05. Waters Corporation had a net margin of 24.26% and a return on equity of 23.91%. The business had revenue of $558.30 million for the quarter, compared to analyst estimates of $553.22 million. During the same quarter in the previous year, the business earned $1.58 earnings per share. The firm’s revenue was up 4.0% compared to the same quarter last year. On average, equities analysts anticipate that Waters Corporation will post $7.38 EPS for the current year.

Waters Corporation declared that its board has authorized a stock buyback plan on Thursday, May 11th that authorizes the company to repurchase $1.00 billion in outstanding shares. This repurchase authorization authorizes the medical instruments supplier to buy up to 7.3% of its stock through open market purchases. Stock repurchase plans are generally an indication that the company’s board believes its shares are undervalued.

In other Waters Corporation news, Director Laurie H. M.D. Glimcher sold 4,800 shares of the business’s stock in a transaction that occurred on Friday, May 19th. The shares were sold at an average price of $175.78, for a total value of $843,744.00. Following the completion of the sale, the director now directly owns 10,849 shares of the company’s stock, valued at $1,907,037.22. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, SVP Rohit Khanna sold 10,000 shares of the business’s stock in a transaction that occurred on Thursday, May 18th. The stock was sold at an average price of $176.46, for a total transaction of $1,764,600.00. Following the completion of the sale, the senior vice president now directly owns 14,077 shares of the company’s stock, valued at $2,484,027.42. The disclosure for this sale can be found here. In the last quarter, insiders sold 98,580 shares of company stock worth $17,730,275. Company insiders own 5.07% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: “Waters Corporation (NYSE:WAT) Receiving Favorable Media Coverage, Analysis Shows” was published by StockNewsTimes and is the property of of StockNewsTimes. If you are reading this piece on another publication, it was copied illegally and republished in violation of U.S. & international trademark and copyright legislation. The legal version of this piece can be viewed at https://stocknewstimes.com/2017/08/12/positive-press-coverage-somewhat-unlikely-to-impact-waters-corporation-nysewat-stock-price-updated-updated.html.

Waters Corporation Company Profile

Waters Corporation is an analytical instrument manufacturer. The Company operates through two segments: Waters and TA. It designs, manufactures, sells and services high performance liquid chromatography (HPLC), ultra performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and post-warranty service plans.

Insider Buying and Selling by Quarter for Waters Corporation (NYSE:WAT)

Receive News & Ratings for Waters Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply